Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjectsSonia Rodriguez-Novoa, Pablo Barreiro, Ana Rendón, et al.
AIDS (London, England)|January 2, 2013
Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapyJosé Vicente Fernández-Montero, Pablo Barreiro, Eugenia Vispo, et al.
Future Microbiology|June 6, 2022
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseasesVicente Soriano, Benson Edagwa, Carmen de Mendoza, et al.
HIV Clinical Trials|October 11, 2005
Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activityMatilde Sánchez-Conde, Carmen de Mendoza, Inmaculada Jiménez-Nacher, et al.
Antiviral Therapy|March 23, 2012
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitorZulema Plaza, Vincent Soriano, Eugenia Vispo, et al.
AIDS (London, England)|September 15, 2004
Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyureaMariola López, José M Benito, Sara Lozano, et al.
HIV Clinical Trials|October 27, 2006
Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patientsCarmen de Mendoza, Luisa Valer, Esteve Ribera, et al.
The Journal of Infectious Diseases|September 2, 2005
Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotypeVincent Soriano, Belen Ramos, Marina Nunez, et al.
Le Infezioni in Medicina|September 23, 2022
Pre-Exposure Prophylaxis for viral infections other than HIVVicente Soriano, Ana Treviño, Carmen de Mendoza, et al.
AIDS Reviews|October 25, 2023
Rebound in sexually transmitted infections after the COVID-19 pandemicVicente Soriano, Hilario Blasco-Fontecilla, Lucía Gallego, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjectsSonia Rodriguez-Novoa, Pablo Barreiro, Ana Rendón, et al.
AIDS (London, England)|January 2, 2013
Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapyJosé Vicente Fernández-Montero, Pablo Barreiro, Eugenia Vispo, et al.
Future Microbiology|June 6, 2022
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseasesVicente Soriano, Benson Edagwa, Carmen de Mendoza, et al.
HIV Clinical Trials|October 11, 2005
Reductions in stavudine dose might ameliorate mitochondrial-associated complications without compromising antiviral activityMatilde Sánchez-Conde, Carmen de Mendoza, Inmaculada Jiménez-Nacher, et al.
Antiviral Therapy|March 23, 2012
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitorZulema Plaza, Vincent Soriano, Eugenia Vispo, et al.
AIDS (London, England)|September 15, 2004
Enhanced HIV-specific immune responses in chronically HIV-infected patients receiving didanosine plus hydroxyureaMariola López, José M Benito, Sara Lozano, et al.
HIV Clinical Trials|October 27, 2006
Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patientsCarmen de Mendoza, Luisa Valer, Esteve Ribera, et al.
The Journal of Infectious Diseases|September 2, 2005
Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotypeVincent Soriano, Belen Ramos, Marina Nunez, et al.
Le Infezioni in Medicina|September 23, 2022
Pre-Exposure Prophylaxis for viral infections other than HIVVicente Soriano, Ana Treviño, Carmen de Mendoza, et al.
AIDS Reviews|October 25, 2023
Rebound in sexually transmitted infections after the COVID-19 pandemicVicente Soriano, Hilario Blasco-Fontecilla, Lucía Gallego, et al.
Pageof 22